The EndoPredict score predicts residual cancer burden after neoadjuvant chemotherapy and after neoendocrince therapy in HR+/HER2-breast cancer patients from ABCSG 34
- PC Dubsky (Author)
- C Fesl (Author)
- CF Singer (Author)
- G Pfeiler (Author)
- R Kronenwett (Author)
- M Hubalek (Author)
- R Bartsch (Author)
- Stöger, H. (Author)
- A Pichler (Author)
- Petru, E. (Author)
- Vesna Bjelic-Radisic (Author)
- R Greil (Author)
- M Rudas (Author)
- MKM Tea (Author)
- V Wette (Author)
- AL Petzner (Author)
- P Sevelda (Author)
- D Egle (Author)
- F Fitzal (Author)
- R Exner (Author)
- R Jakesz (Author)
- Balic, M. (Author)
- C Tinchon (Author)
- Z Bago Horvath (Author)
- S Lax (Author)
- Regitnig, P. (Author)
- M Gnant (Author)
- M Filipits (Author)
Activity: Talk, presentation or poster › Scientific talk or presentation › On site